ARCHIVES

FDA, ASCO Meet to Review Drug Approval Endpoints

This article is from The Cancer Letter archive.

Vol. 29 No. 17 | April 25, 2003

Download PDF Visit The Full Archive

Related Articles

CCIRC Considers Programs Involved with Including Multimodality Studies

October 10, 1975

In Brief: Adamson’s Appointment Official As DCCP Director; NCI Holds Current Spending To 12 Percent Level

October 23, 1981

Bristol-Myers Awards 42.5 Million In Cancer Grants

October 21, 1977

Also Senate approves spending bill.

January 23, 2004

In Brief: DeVita, FDA Chief Help Kill California Bill Legalizing Laetrile Wit committee Testimony

August 26, 1977

Cancer Letter Skips Next Two Weeks

September 2, 1988